EB
Emily Bodnar HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
107
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
94.4%
Neutral
5.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $19 |
702%
upside
| 1 | -20% |
0
%
| 25 Nov ‘25 10 days ago |
|
|
|
Buy
Maintained
| $51 |
15%
upside
| 3 | +18% |
0
%
| 24 Nov ‘25 11 days ago |
|
|
|
Buy
Maintained
| $48 |
73%
upside
| 1 | -1.9% |
0
%
| 20 Nov ‘25 15 days ago |
|
|
|
Buy
Maintained
| $36 |
32%
upside
| 2 | +32% |
0
%
| 18 Nov ‘25 17 days ago |
|
|
|
Buy
Maintained
| $15 |
346%
upside
| 1 | +33% |
0
%
| 12 Nov ‘25 23 days ago |
|
|
|
Buy
Maintained
| $9 |
75%
upside
| 1 | +48% |
0
%
| 7 Nov ‘25 28 days ago |
|
|
|
Buy
Maintained
| $5 |
376%
upside
| 1 | +15% |
0
%
| 6 Nov ‘25 29 days ago |
|
|
|
Buy
Upgraded
| $18 |
106%
upside
| 1 | +7.9% |
0
%
| 5 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $42 |
247%
upside
| 1 | -30% |
0
%
| 30 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $28 |
10%
upside
| 1 | +61% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $72 |
109%
upside
| 1 | +95% |
0
%
| 27 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $12 |
463%
upside
| 1 | +27% |
0
%
| 14 Oct ‘25 1 month ago |
|
|
|
Buy
Assumed
| $60 |
95%
upside
| 1 | -16% |
0
%
| 6 Oct ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | +32% |
0
%
| 29 Sep ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $23 |
485%
upside
| 1 | -6.6% |
0
%
| 10 Sep ‘25 2 months ago |
|